Who we are
   
Facilities
 
   
 

JOGESHWARI, MUMBAI

ROHA, MAHARASHTRA

SINNAR, MAHARASHTRA

AURANGABAD (WALUJ), MAHARASHTRA

VERNA,GOA I & II PLANT

BADDI, HIMACHAL PRADESH

 

JOGESHWARI, MUMBAI
 
 
  • Dosage form: Oral Solids-Tablets
  • Capacity: 240 million tablets/yr
  • Approvals: WHO–GMP, UNICEF
  • Corporate R & D center: for Formulations, APIs, Foods and Biotechnology
  • Corporate Head Office: Materials Management, Marketing, Finance and International Business
ROHA, MAHARASHTRA
 
 
  • API Plant
  • Capacity: 73000 kg/yr
  • Approvals: WHO – GMP, US -FDA
SINNAR, MAHARASHTRA
 
 
  • Dosage form: Oral Rehydration Salt Powder
  • Capacity: 108 million ORS sachets/yr
  • Approvals: WHO, UNICEF, UGANDA , MSF France
  • World's Largest ORS manufacturing plant: delivers impeccable quality ORS in FFS Sachets
  • Completely integrated lines: manufacturing, filling, sealing and packing
AURANGABAD (WALUJ), MAHARASHTRA
 
 
  • Dosage forms: Sterile Ophthalmic Preparations in BFS - LDPE vials offering 5ml, 10ml, 15ml and single dose vials (unims) in 0.5ml., Liquid Oral Solutions, Oral Rehydration Salt Powder, and External Powder preparations.
  • Capacity:
    • 38.4 million vials/yr (Sterile Ophthalmic)
    • 9.6 million liquid oral bottles/yr
    • 73.2 million ORS sachets/yr
    • 3.6 million external powder containers/yr
  • Approvals: •  WHO-GMP, MCC- South Africa, UK-MHRA, ANVISA Brazil, US-FDA, ISO 9001:2000, 13485:2003
  • Unique Technology:
    • BFS technology for ophthalmic preparations
    • FFS technology for ORS preparations in sachets
    • Integrated lines for manufacturing, filling, sealing and packing
VERNA, GOA (PLANTS I & II)
 
 
  • Goa I: Oral Solid Dosage - Tablets & Capsules
  • Goa II: Oral Rehydration Salt Powder
  • Capacity:
    • 48 million capsules/yr
    • 360 million tablets/yr
    • 54 million ORS sachets/yr
  • Approvals: WHO - GMP, UK-MHRA (Goa I), MCA (Zimbabwe), UNICEF
  • Unique Technology:
    • FFS technology for ORS Sachets
    • Integrated lines for manufacturing, filling, sealing and packing
    • Total manufacturing area under class 100000
VERNA, GOA (PLANT III)
 
 
  • Dosage form: Tablets
  • Capacity: 1200 million tablets/yr
  • Designed to meet UK-MHRA and US-FDA requirements
  • Salient attributes:
    • Provision for ANDA batches
    • High-speed and high-output manufacturing equipment and machines
    • Total manufacturing area under class 100000
    • Integrated lines for manufacturing, filling, sealing and packing
BADDI, HIMACHAL PRADESH
  • Cephalosporin dosage forms: Tablets, Capsules and Oral Liquids
  • Capacity:
    • 480 million tablets/yr
    • 14.4 million liquid oral bottles/yr
    • 120 million capsules/yr
  • Designed to meet: UK-MHRA and US-FDA regulatory requirements
  • Salient attributes:
    • Dedicated Plant for cephalosporin dosage forms
    • Complete manufacturing area under class 100000
    • Integrated lines for manufacturing, filling, sealing and packing to avoid mix ups